Litcius/Paper detail

Targeting HER2-positive breast cancer: advances and future directions

Sandra M. Swain, Mythili Shastry, Erika Hamilton

2022Nature Reviews Drug Discovery1,075 citationsDOIOpen Access PDF

Topics & Concepts

TrastuzumabMedicineBreast cancerTargeted therapyMonoclonal antibodyClinical trialCancerDrugOncologyAntibodyPharmacologyImmunologyInternal medicineHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchPeptidase Inhibition and Analysis
Targeting HER2-positive breast cancer: advances and future directions | Litcius